Information  X 
Enter a valid email address

British Land Co PLC (BLND)

  Print      Mail a friend

Wednesday 12 June, 2019

British Land Co PLC

Transaction in Own Shares

RNS Number : 0216C
British Land Co PLC
12 June 2019
 

British Land Co PLC




12 June 2019















Transaction in own shares







The British Land Company PLC (the "Company") announces that it has purchased through UBS AG London Branch ("UBS") the following number of its ordinary shares of 25 pence each on the London Stock Exchange. The purchases were made pursuant to the buy-back programme announced by the Company on 15 May 2019. The Company intends to cancel the purchased shares.







Number of Shares purchased:

2,500



Volume weighted average price paid per Share (pence):

539.1687



Highest price paid per Share (pence):

539.8



Lowest price paid per Share (pence):

538.2



Date of purchase:

12 June 2019








In accordance with Article 5(1)(b) of EU Market Abuse Regulation (596/2014), detailed information about the individual purchases made by UBS on behalf of the Company as part of the buy-back programme is set out below.







Enquiries:










Company Secretariat





British Land

020 7486 4466









Transaction details





Issuer name: The British Land Company PLC




(ISIN: GB0001367019 LEI Code: RV5B68J2GV3QGMRPW209)




Intermediary name: UBS AG London Branch




(Intermediary code: UBSWGB2L)









Individual transactions










Number of shares
purchased

Transaction price per share (pence)

Time of transaction



208

539

10:15:27



205

539

12:10:35



218

538

14:10:18



207

539

15:40:20



319

540

15:54:14



312

540

16:10:17



162

540

16:17:58



327

540

16:18:32



338

538

16:23:13



168

539

16:28:06



36

539

16:28:06


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSLLFEERAIFLIA

a d v e r t i s e m e n t